NCT05112406

Brief Summary

A Comparison between CRP, ferritin, and serum zinc as early diagnostic biomarkers of sepsis in critically ill patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
23 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

November 8, 2021

Status Verified

November 1, 2021

Enrollment Period

1 year

First QC Date

October 27, 2021

Last Update Submit

November 5, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Study of some biomarkers as indicators of sepsis.

    Measurement of CRP as early diagnostic biomarker of sepsis

    about 2 years

  • Study of some biomarkers as indicators of sepsis.

    Measurement of ferritin as early diagnostic biomarker of sepsis

    about 2 years

  • Study of some biomarkers as indicators of sepsis.

    Measurement of serum Zinc as early diagnostic biomarker of sepsis

    about 2 years

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients above 18 years old with systemic infection that may lead to sepsis.

You may qualify if:

  • All patients with chest infection and UTI.

You may not qualify if:

  • children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Critical IllnessSepsis

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsInfectionsSystemic Inflammatory Response SyndromeInflammation

Central Study Contacts

Michael Kamile, MBBD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

October 27, 2021

First Posted

November 8, 2021

Study Start

December 1, 2021

Primary Completion

December 1, 2022

Study Completion

March 1, 2023

Last Updated

November 8, 2021

Record last verified: 2021-11